Novogene Co

Novogene Co Market capitalization

The The market capitalization of Novogene Co (688315.SS) as of Nov 15, 2026 is 6.36 B CNY. In the previous year, The market capitalization was 6.36 B CNY — a change of 0.00% (lower).

Market capitalization

6.36 BCNY

YoY

0.00%

Last updated:

In 2025, Novogene Co's market cap stood at 6.36 B CNY, a 0.00% increase from the 6.36 B CNY market cap in the previous year.

The Novogene Co Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
6.36 B CNY
Jan 1, 2019
6.36 B CNY
Jan 1, 2020
6.36 B CNY
Jan 1, 2021
6.36 B CNY
Jan 1, 2022
6.36 B CNY
Jan 1, 2023
6.36 B CNY
Jan 1, 2024
6.36 B CNY
Jan 1, 2025
6.36 B CNY
The Novogene Co Market capitalization history
YEARMarket capitalizationYoY
6.36 BCNY0.00%
6.36 BCNY0.00%
6.36 BCNY0.00%
6.36 BCNY0.00%
6.36 BCNY0.00%
6.36 BCNY0.00%
6.36 BCNY0.00%
6.36 BCNY0.00%
6.36 BCNY0.00%
6.36 BCNY0.00%
6.36 BCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Novogene Co Stock analysis

What does Novogene Co do? Novogene Co., Ltd. generates revenue through genomic services and solutions, primarily utilizing high-throughput sequencing and bioinformatics analysis technologies. The company offers life science basic research services, medical research and technical services, and database-building sequencing platform services, targeting both domestic and international markets. Key products include gene mutation detection kits, coronavirus disease nucleic acid test services, and DA8600 sequencers, which are sold to research institutions, medical facilities, and clinical applications. The firm's technology-driven approach enables it to provide multi-level scientific and research technical services across life science and medical fields. Novogene's revenue streams are anchored in its sequencing platforms and equipment, with the DA8600 sequencers representing a significant product line. The company develops and sells genetic testing medical equipment, leveraging its expertise in gene sequencing. Its services are tailored for life science basic research, medical and clinical applications, and database construction, serving a diverse clientele including research organizations and healthcare providers. The firm's focus on multi-omics research technology enhances its ability to deliver comprehensive solutions. The business model integrates high-throughput sequencing technology with bioinformatics analysis to create scalable services. Novogene's offerings span from basic research support to clinical diagnostic tools, with gene mutation detection kits and coronavirus disease nucleic acid test services catering to specific market needs. The company's domestic and overseas market presence ensures broad client reach, while its independent development of sequencing equipment like the DA8600 sequencers drives product-based revenue. This dual focus on services and equipment positions Novogene as a key player in genomic technology solutions. Novogene Co is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Novogene Co's Market Capitalization

Novogene Co's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Novogene Co's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Novogene Co's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Novogene Co’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Novogene Co stock

The market capitalization of Novogene Co is 6.36 B CNY in 2025.

The market capitalization of Novogene Co changed from 6.36 B CNY to 6.36 B CNY, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Novogene Co since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's CNY, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' CNY varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Novogene Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Novogene Co

All Key Metrics — Novogene Co